Public-registry site landscape for NCT05199337, a Amyloidosis study sponsored by K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05199337 (registry record) |
| Sponsor | K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. |
| Condition(s) | Amyloidosis; AL Amyloidosis |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 21 |
| Site countries | United States, Australia, Cyprus, Greece, Israel, Italy, Spain |
Eichor generates a preliminary site-risk snapshot for NCT05199337 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →